Pralsetinib
N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
Molecular Identity
Pralsetinib
N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
PubChem CID: 129073603
2D Structure
Properties
C27H32FN9O2
Molecular Formula
533.60
Molecular Weight
g/mol
533.2663
Exact Mass
Da
3.1
XLogP
Drug-like (Lipinski: < 5)
136
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
9
H-Bond Acceptors
816
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Pralsetinib2097132-94-8BLU-667Blu667trans-Pralsetinib2097132-93-7Pralsetinib free baseGavretoPralsetinib, cis-cis-PralsetinibPralsetinib [INN]Pralsetinib [USAN]BLU1232441WPE73O1WVN-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Pralsetinib
Loading drug network...